Exthera Medical Corporation

This study tests a blood purification device in 15 critically ill adults with septic shock (a severe infection causing dangerously low blood pressure). The treatment filters the blood to remove harmful germs and toxins. The goal is to see if it is safe and helps patients leave th…

This study planned to test a blood-filtering device called Seraph 100 in 100 adults with Long COVID. Participants would receive two treatments on consecutive days and be checked after 3 days and 4 weeks. However, the trial was withdrawn before any patients enrolled, so no results…

This study is testing a device called the Seraph 100, which filters a patient's blood to remove the COVID-19 virus. It aims to help adults hospitalized with severe COVID-19 by reducing organ failure and improving survival. The main goal is to see if the filter is safe and if it h…